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Dear Sir, 
We read with great interest the study of Pareja et al. (1) entitled: ”A score 
model for the continuous grading of early allograft dysfunction severity”, reporting a 
new score characterizing severity of early allograft dysfunction (EAD) so called the 
MEAF (model of early allograft function) score. This interesting score, which is 
calculated from bilirubin, INR and alanine aminotransferase levels observed within 
the 3 first post operative day (POD), is a continuous score grading from 0 to 10 
reflecting the graft function, while most of previous score including the definition of 
EAD reported by Olthoff and al. (2), are only binary. In order to validate the proposed 
model we calculated the MEAF score in our population according to the reported 
formula. Between 2002 and 2014, 1297 liver transplantation were performed in our 
center with a median follow up of 41.4 months. Thirty two (2.5%) patients were 
retransplanted or died within the 2 first POD and were therefore excluded from the 
analysis. Of the 1265 remaining patients, the MEAF score could be calculated in 785 
(62%) cases. 
Median MEAF score value was 4.6 and a significant correlation with graft survival 
was observed (figure 1a). Notwithstanding, the capacity of a MEAF score ≥ 8 to 
predict 35months graft survival was inferior to presence of EAD (as reported by 
Olthoff et al.) as shown by ROC curve (figure 1.b). 
Therefore, our data support the effectiveness of the MEAF score as a grading system 
of the severity of graft dysfunction. However, it is our opinion that this score has 
some limitations. First, it can’t be calculated in case of graft or patient death within 
the 2 first POD. This major limitation, prevent comparison or analysis of liver 
transplantation efficiency between subgroup or population as most of patient with 
primary non function, requiring early retransplantation, were excluded. We suggest 
that patients in whom the MEAF score could not be calculated due to 
retransplantation or patient’s death, should be attributed by default the maximum 
score (i.e. 10). Moreover, its formula required a calculator and therefore limits its 
utility in clinical practice. A more simple method of calculation, which could be easily 
used by physician, may be useful. 
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Figure legends: 
 
Figure 1 A- Graft survival according to MEAF score stratification. p value <0.001. 
B- Comparision of three5months graft survival prediction with MEAF and EAD by 
ROC curve 
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Figure 1 A- Graft survival according to MEAF score stratification. p value <0.001.  
B- Comparision of three-months graft survival prediction with MEAF and EAD by ROC curve 
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